Literature DB >> 7049310

Experiences with cadaver renal allograft contamination before transplantation.

E K Spees, J A Light, D D Oakes, B Reinmuth.   

Abstract

Microbial contamination occurred in 23 (13 per cent) of 177 cadaver donor kidneys prior to renal transplantation. In 16 cases there were no complications directly attributable to the organisms recovered from the preservation media. Three patients developed perinephric infections associated with renal artery anastomotic disruption and required emergency transplant nephrectomy. A fourth patient developed renal artery stenosis and a hypogastric artery aneurysm that required correction 6 months later with preservation of renal allograft function. In 3 cases no follow-up information was available. None of the 154 uncontaminated kidneys developed arterial disruption or aneurysm. Candida albicans and Pseudomonas aeruginosa infections were responsible for the nearly disastrous arterial disruptions and possibly the hypogastric arterial aneurysm. These findings demonstrate the importance of bacteriological surveillance of perfusion media to detect nosocomial infection, to guide antibiotic chemotherapy and to direct surgical management of septic complications. In our experience contamination was not necessarily incompatible with long term satisfactory results; however, when complications did occur they were serious. It is likely that the size of the microbial inoculum, the patient's immune competence and the protective effect of antibiotic therapy administered to the donor and recipient affected the eventual outcome.

Entities:  

Mesh:

Year:  1982        PMID: 7049310     DOI: 10.1002/bjs.1800690819

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Risk factors for multidrug-resistant organisms among deceased organ donors.

Authors:  Judith A Anesi; Emily A Blumberg; Jennifer H Han; Dong H Lee; Heather Clauss; Antonette Climaco; Richard Hasz; Esther Molnar; Darcy Alimenti; Sharon West; Warren B Bilker; Pam Tolomeo; Ebbing Lautenbach
Journal:  Am J Transplant       Date:  2019-06-26       Impact factor: 8.086

2.  [Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].

Authors:  R Grundmann; P Wienand; G Meider; V Vlaho; H Pichlmaier
Journal:  Klin Wochenschr       Date:  1984-10-15

3.  Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method.

Authors:  Meirigeng Qi; Keiko Omori; Yoko Mullen; Brian McFadden; Luis Valiente; Jemily Juan; Shiela Bilbao; Bernard R Tegtmeier; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2016-02

4.  Impact of deceased donor multidrug-resistant bacterial organisms on organ utilization.

Authors:  Judith A Anesi; Jennifer H Han; Ebbing Lautenbach; Dong H Lee; Heather Clauss; Antonette Climaco; Warren B Bilker; Richard Hasz; Esther Molnar; Darcy Alimenti; Sharon West; Pam Tolomeo; Emily A Blumberg
Journal:  Am J Transplant       Date:  2020-03-12       Impact factor: 9.369

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.